BlueBox Precision Medicine Fund A
LU2519372499
BlueBox Precision Medicine Fund A/ LU2519372499 /
NAV13/06/2024 |
Chg.0.0000 |
Type of yield |
Investment Focus |
Investment company |
1,130.2300USD |
0.00% |
reinvestment |
Equity
Worldwide
|
Fuchs Asset M. ▶ |
Investment strategy
The main objective of the Fund is to seek to maximise total return.
The Fund invests globally with at least 85% of its total assets in the equity securities of companies whose predominant economic activity is in the pharmaceuticals, biotechnology and life science sectors. The overall investment strategy of the BlueBox Precision Medicine Fund is to seek out companies that will create value for the Shareholders from precision medicine: the multi-year trend of increasingly precise and targeted drug development in the pharmaceutical and biotechnology industries. The BlueBox Precision Medicine Fund will typically hold 25 to 45 positions. The holding periods are expected to be generally long (multiple years) and turnover low, although at times the BlueBox Precision Medicine Fund may utilise shorter holding periods if value is realised more quickly or unexpected events occur.
Investment goal
The main objective of the Fund is to seek to maximise total return.
Master data
Type of yield: |
reinvestment |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Health / Pharma |
Benchmark: |
- |
Business year start: |
01/01 |
Last Distribution: |
- |
Depository bank: |
Northern Trust Global Services SE |
Fund domicile: |
Luxembourg |
Distribution permission: |
Germany, Switzerland |
Fund manager: |
Mark Dainty |
Fund volume: |
15.86 mill.
USD
|
Launch date: |
14/06/2023 |
Investment focus: |
- |
Conditions
Issue surcharge: |
5.00% |
Max. Administration Fee: |
1.50% |
Minimum investment: |
10,000.00 USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Key Investor Information: |
- |
Investment company
Funds company: |
Fuchs Asset M. |
Address: |
49,boulevard Prince Henri, 1724, Luxembourg |
Country: |
Luxembourg |
Internet: |
info@fuchsgroup.com
|
Assets
Stocks |
|
98.20% |
Cash and Other Assets |
|
1.80% |
Countries
United States of America |
|
72.40% |
United Kingdom |
|
6.00% |
Belgium |
|
5.90% |
France |
|
5.30% |
Switzerland |
|
3.10% |
Italy |
|
3.00% |
Denmark |
|
2.50% |
Others |
|
1.80% |
Branches
Pharma/Biotechnology |
|
64.90% |
Pharma, production |
|
3.00% |
Cash / other assets |
|
1.80% |
Others |
|
30.30% |